GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 802 filers reported holding GLAXOSMITHKLINE PLC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $19,000 | -24.0% | 445 | -33.1% | 0.01% | 0.0% |
| Q3 2021 | $25,000 | -3.8% | 665 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $26,000 | +8.3% | 665 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $24,000 | 0.0% | 665 | 0.0% | 0.01% | -10.0% |
| Q4 2020 | $24,000 | +9.1% | 665 | +12.5% | 0.01% | -9.1% |
| Q3 2020 | $22,000 | -8.3% | 591 | 0.0% | 0.01% | -15.4% |
| Q2 2020 | $24,000 | +4.3% | 591 | 0.0% | 0.01% | -55.2% |
| Q1 2020 | $23,000 | -28.1% | 591 | -21.8% | 0.03% | +38.1% |
| Q3 2019 | $32,000 | +3.2% | 756 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $31,000 | 0.0% | 756 | 0.0% | 0.02% | -4.5% |
| Q1 2019 | $31,000 | +6.9% | 756 | 0.0% | 0.02% | -4.3% |
| Q4 2018 | $29,000 | -6.5% | 756 | 0.0% | 0.02% | +9.5% |
| Q3 2018 | $31,000 | +19.2% | 756 | +17.0% | 0.02% | +10.5% |
| Q2 2018 | $26,000 | -60.0% | 646 | -61.2% | 0.02% | -60.4% |
| Q1 2018 | $65,000 | – | 1,665 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |